Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · January 30, 2020

Brolucizumab: Evolution Through Preclinical and Clinical Studies, and the Implications for the Management of nAMD

Ophthalmology

 

Additional Info

Ophthalmology
Brolucizumab: Evolution Through Preclinical and Clinical Studies, and the Implications for the Management of nAMD
Ophthalmology 2020 Jan 17;[EPub Ahead of Print], QD Nguyen, A Das, DV Do, et al

Further Reading